Updated: 4/14/2020

Filgrastim / Sargramostim

Review Topic
  • A 45-year-old woman undergoing chemotherapy for breast cancer undergoes routine laboratory work-up. A complete blood count is significant for neutropenia and anemia. She has been on filgrastim for chemotherapy-related neutropenia. She follows up with her medical oncologist, who suggests switching to sargramostim, which works in a slightly different mechanism.
  • Drugs
    • filgrastim
      • recombinant human granulocyte-colony stimulating factor (G-CSF)
    • pegfilgrastim
      • recombinant PEG-conjugated human G-CSF
    • sargramostim
      • recombinant granulocyte macrophage CSF (GM-CSF)
  • Mechanism of action
    • G-CSF
      • stimulates production of neutrophils
    • GM-CSF
      • stimulates production of neutrophils, dendritic cells, and monocytes/macrophages
  • Clinical use
    • neutropenia
      • myelosuppressive chemotherapy
      • aplastic anemia
      • congenital neutropenia
    • stem cell transplantation
  • Adverse effects
    • nausea and vomiting
    • bone pain
    • cutaneous vasculitis
    • allergic reaction
      • angioedema
      • urticaria
      • anaphylaxis
    • thrombocytopenia
    • capillary leak syndrome
    • leukocytosis

Please rate topic.

Average 4.8 of 6 Ratings

Thank you for rating! Please vote below and help us build the most advanced adaptive learning platform in medicine

The complexity of this topic is appropriate for?
How important is this topic for board examinations?
How important is this topic for clinical practice?
Topic COMMENTS (1)
Private Note